Re: ZEN-3694 mCRPC Trial Status

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Nextblockbuster

Rank: President [?]

Points: 2717 [?]

Votes: 15 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: ZEN-3694 mCRPC Trial Status

in response to

ZEN-3694 mCRPC Trial Status

BearDownAZ

posted on Oct 24, 2017 12:04PM

Which beg the question whether or not Pfizer or another pharma is knocking on the door and wants in now or will they wait it out til a phase 3 trial is completed.....

4 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply